POHL DAVID 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed May 8, 2013
Insider Transaction Report
Form 4
POHL DAVID
Director
Transactions
- Award
Stock Option (right to buy)
2013-05-06+250,000→ 1,352,000 totalExercise: $1.41From: 2013-08-06Exp: 2023-05-06→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This option vests in eight (8) equal quarterly installments over a two (2) year period beginning August 6, 2013 and each quarter thereafter until fully-vested.